SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR XA INHIBITORS

This invention is directed to oxoazaheterocyclyl compounds which inhibit factor Xa, to pharmaceutical compositions comprising these compounds, to intermediates useful for preparing these compounds and to a method of inhibiting factor Xa.

Saved in:
Bibliographic Details
Main Authors MYERS, MICHAEL R, EWING, WILLIAM R, LI, AIWEN, POLI, GREGORY B, LAU, WAN F, BECKER, MICHAEL R, CONDON, STEPHEN M, PAULS, HEINZ W, BURNS, CHRISTOPHER J, HANNEY, BARBARA A, SPADA, ALFRED P, HE, WEI, JIANG, JOHN Z, CHOI-SLEDESKI, YONG MI, DAVIS, RODERICK S
Format Patent
LanguageEnglish
French
Published 22.02.2011
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract This invention is directed to oxoazaheterocyclyl compounds which inhibit factor Xa, to pharmaceutical compositions comprising these compounds, to intermediates useful for preparing these compounds and to a method of inhibiting factor Xa.
AbstractList This invention is directed to oxoazaheterocyclyl compounds which inhibit factor Xa, to pharmaceutical compositions comprising these compounds, to intermediates useful for preparing these compounds and to a method of inhibiting factor Xa.
Author CHOI-SLEDESKI, YONG MI
EWING, WILLIAM R
PAULS, HEINZ W
JIANG, JOHN Z
POLI, GREGORY B
BURNS, CHRISTOPHER J
DAVIS, RODERICK S
LI, AIWEN
HE, WEI
MYERS, MICHAEL R
LAU, WAN F
HANNEY, BARBARA A
BECKER, MICHAEL R
CONDON, STEPHEN M
SPADA, ALFRED P
Author_xml – fullname: MYERS, MICHAEL R
– fullname: EWING, WILLIAM R
– fullname: LI, AIWEN
– fullname: POLI, GREGORY B
– fullname: LAU, WAN F
– fullname: BECKER, MICHAEL R
– fullname: CONDON, STEPHEN M
– fullname: PAULS, HEINZ W
– fullname: BURNS, CHRISTOPHER J
– fullname: HANNEY, BARBARA A
– fullname: SPADA, ALFRED P
– fullname: HE, WEI
– fullname: JIANG, JOHN Z
– fullname: CHOI-SLEDESKI, YONG MI
– fullname: DAVIS, RODERICK S
BookMark eNrjYmDJy89L5WQwDg51Cg7xDAkNcXVR8I_wd4xy9HANcQ3yd4509on0UXBzdA7xD1KIcFTw9PPwdPIEcoJ5GFjTEnOKU3mhNDeDvJtriLOHbmpBfnxqcUFicmpeakm8s6ORsaGloaWFszFhFQBHnyic
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate COMPOSES OXOAZAHETEROCYCLYLE SUBSTITUES INHIBITEURS DU FACTEUR XA
ExternalDocumentID CA2319198C
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2319198C3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:14:52 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2319198C3
Notes Application Number: CA19992319198
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110222&DB=EPODOC&CC=CA&NR=2319198C
ParticipantIDs epo_espacenet_CA2319198C
PublicationCentury 2000
PublicationDate 20110222
PublicationDateYYYYMMDD 2011-02-22
PublicationDate_xml – month: 02
  year: 2011
  text: 20110222
  day: 22
PublicationDecade 2010
PublicationYear 2011
RelatedCompanies AVENTIS PHARMACEUTICALS PRODUCTS INC
RelatedCompanies_xml – name: AVENTIS PHARMACEUTICALS PRODUCTS INC
Score 2.7983983
Snippet This invention is directed to oxoazaheterocyclyl compounds which inhibit factor Xa, to pharmaceutical compositions comprising these compounds, to intermediates...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR XA INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110222&DB=EPODOC&locale=&CC=CA&NR=2319198C
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT4NAEJ7UatSbVk19czDciO0CbTkQAwsETO02LTXUS8OybPRSG4vx7ztgUS-9bPaRzD6Sb167MwtwZ4lUmsTiGqriQjO4MdAGPSyIkaZE9HPBsyrb56gXzozHxEwa8FrHwlR5Qr-q5IiIqAzxXlT8evXnxPKqt5Xre_6GXe8PQWx7qqjdfaX9onqu7Y-Zx6hKqU0ddTSxUY2x0L6mO7CLSnS_xIL_7JYxKav_AiU4gr0x0loWx9DIly04oPW_ay3Yf9pcd2N1g7z1CejTmTuNo3iGnEZhCXNenNBHVZTROR3Oh0rg0JhNlMRRolEYuRE2pqdwG_gxDTWcffG70QV16mXqZ9BE8z9vg9IxxUDKrpWlfd3oGJzjycpcCpKJLpe6PIf2NioX24cu4fDHO0o0Qq6gWXx85tcoXgt-U53MN5M-e9g
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT4NAEJ7Uaqw3rZr6LAfDjdgu9MGBGFggoBSalhrqpWFZNnqpjcX4951iUS-9bPaRzD6Sb167Mwtwp_NU9IjOFFTFuaIxbagM-1gQLU0JH-ScZWW2z7DvzbTHpJfU4LWKhSnzhH6VyRERURnivSj59erPiWWXbyvX9-wNu94f3NiwZV65-zb2i2xbhjOO7IjKlBrUlMOJgWqMjvY13YN9VLAHGyw4z9YmJmX1X6C4x3AwRlrL4gRq-bIJDVr9u9aEw9H2uhurW-StT0Gdzqxp7Mcz5DRSlETmi-k5qIpGdE6DeSC5Jo2jiZSYkh96vuVjY3oGbdeJqafg7IvfjS6oWS1TPYc6mv95C6ROjw-F6OpZOlC1jsYYnqzIBScZ7zKhigto7aJyuXuoDQ0vHgWLwA-fruDox1NKFEKuoV58fOY3KGoLdlue0jeNeH7L
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SUBSTITUTED+OXOAZAHETEROCYCLYL+FACTOR+XA+INHIBITORS&rft.inventor=MYERS%2C+MICHAEL+R&rft.inventor=EWING%2C+WILLIAM+R&rft.inventor=LI%2C+AIWEN&rft.inventor=POLI%2C+GREGORY+B&rft.inventor=LAU%2C+WAN+F&rft.inventor=BECKER%2C+MICHAEL+R&rft.inventor=CONDON%2C+STEPHEN+M&rft.inventor=PAULS%2C+HEINZ+W&rft.inventor=BURNS%2C+CHRISTOPHER+J&rft.inventor=HANNEY%2C+BARBARA+A&rft.inventor=SPADA%2C+ALFRED+P&rft.inventor=HE%2C+WEI&rft.inventor=JIANG%2C+JOHN+Z&rft.inventor=CHOI-SLEDESKI%2C+YONG+MI&rft.inventor=DAVIS%2C+RODERICK+S&rft.date=2011-02-22&rft.externalDBID=C&rft.externalDocID=CA2319198C